Rani Therapeutics Holdings, Inc.
RANI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $39 | $85 | $141 | $322 |
| - Cash | $4 | $6 | $27 | $117 |
| + Debt | $30 | $30 | $30 | $0 |
| Enterprise Value | $65 | $109 | $144 | $205 |
| Revenue | $1 | $0 | $0 | $3 |
| % Growth | – | – | -100% | – |
| Gross Profit | $1 | -$1 | $0 | $3 |
| % Margin | 100% | – | – | 100% |
| EBITDA | -$51 | -$65 | -$62 | -$52 |
| % Margin | -4,914.7% | – | – | -1,917% |
| Net Income | -$30 | -$34 | -$31 | -$8 |
| % Margin | -2,920% | – | – | -306.6% |
| EPS Diluted | -1.05 | -1.33 | -1.28 | -0.42 |
| % Growth | 21.1% | -3.9% | -204.8% | – |
| Operating Cash Flow | -$35 | -$51 | -$47 | -$32 |
| Capital Expenditures | -$0 | -$1 | -$2 | -$1 |
| Free Cash Flow | -$36 | -$52 | -$48 | -$33 |